Axogen

Axogen, Inc. announced a definitive agreement to acquire BioCircuit Technologies, Inc. for $200 million in cash. The acquisition adds NerveTape, the first FDA-approved device for sutureless peripheral nerve repair, and is expected to close in Q4 2026.